These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33992678)

  • 1. Timosaponin BII improved osteoporosis caused by hyperglycemia through promoting autophagy of osteoblasts via suppressing the mTOR/NFκB signaling pathway.
    Wang N; Xu P; Wu R; Wang X; Wang Y; Shou D; Zhang Y
    Free Radic Biol Med; 2021 Aug; 171():112-123. PubMed ID: 33992678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipidomics Analysis of Timosaponin BII in INS-1 Cells Induced by Glycolipid Toxicity and Its Relationship with Inflammation.
    Shi K; Zhu J; Chen D; Ren C; Guo M; Wang J; Wu X; Feng Y
    Chem Biodivers; 2020 Apr; 17(4):e1900684. PubMed ID: 32064755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timosaponin AIII attenuates inflammatory injury in AGEs-induced osteoblast and alloxan-induced diabetic osteoporosis zebrafish by modulating the RAGE/MAPK signaling pathways.
    Wang N; Xu P; Wang X; Yao W; Wang B; Wu Y; Shou D
    Phytomedicine; 2020 May; 75():153247. PubMed ID: 32502823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timosaponin B-II ameliorates diabetic nephropathy via TXNIP, mTOR, and NF-κB signaling pathways in alloxan-induced mice.
    Yuan YL; Guo CR; Cui LL; Ruan SX; Zhang CF; Ji D; Yang ZL; Li F
    Drug Des Devel Ther; 2015; 9():6247-58. PubMed ID: 26664046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timosaponin AIII is preferentially cytotoxic to tumor cells through inhibition of mTOR and induction of ER stress.
    King FW; Fong S; Griffin C; Shoemaker M; Staub R; Zhang YL; Cohen I; Shtivelman E
    PLoS One; 2009 Sep; 4(9):e7283. PubMed ID: 19789631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timosaponin-BII inhibits the up-regulation of BACE1 induced by ferric chloride in rat retina.
    Huang JF; Shang L; Liu P; Zhang MQ; Chen S; Chen D; Fan CL; Wang H; Xiong K
    BMC Complement Altern Med; 2012 Oct; 12():189. PubMed ID: 23082924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coordinate regulatory osteogenesis effects of icariin, timosaponin B II and ferulic acid from traditional Chinese medicine formulas on UMR-106 osteoblastic cells and osteoblasts in neonatal rat calvaria cultures.
    Li M; Zhang ND; Wang Y; Han T; Jiang YP; Rahman K; Qin LP; Xin HL; Zhang QY
    J Ethnopharmacol; 2016 Jun; 185():120-31. PubMed ID: 26983755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monotropein attenuates oxidative stress via Akt/mTOR-mediated autophagy in osteoblast cells.
    Shi Y; Liu XY; Jiang YP; Zhang JB; Zhang QY; Wang NN; Xin HL
    Biomed Pharmacother; 2020 Jan; 121():109566. PubMed ID: 31698268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Pathways Involved in Promoting Activity of Timosaponin BII on Hair Growth in C57BL/6 Mice.
    Xiao L; Zhang X; Chen Z; Li J; Li B; Li L
    Biomed Res Int; 2020; 2020():9451596. PubMed ID: 33015188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timosaponin A‑III induces autophagy of T‑cell acute lymphoblastic leukemia Jurkat cells via inhibition of the PI3K/Akt/mTOR pathway.
    Wang H; Dong R; Fan WW; Zheng XC; Li AM; Wang WD
    Oncol Rep; 2019 May; 41(5):2937-2944. PubMed ID: 30896824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin alleviates dexamethasone-induced apoptosis by regulating autophagy via AMPK/mTOR/p70S6K in osteoblasts.
    Guo X; Liang M
    Exp Cell Res; 2022 Jun; 415(1):113120. PubMed ID: 35341775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biotransformation of Timosaponin BII into Seven Characteristic Metabolites by the Gut Microbiota.
    Dong GM; Yu H; Pan LB; Ma SR; Xu H; Zhang ZW; Han P; Fu J; Yang XY; Keranmu A; Niu HT; Jiang JD; Wang Y
    Molecules; 2021 Jun; 26(13):. PubMed ID: 34202717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estradiol inhibits osteoblast apoptosis via promotion of autophagy through the ER-ERK-mTOR pathway.
    Yang YH; Chen K; Li B; Chen JW; Zheng XF; Wang YR; Jiang SD; Jiang LS
    Apoptosis; 2013 Nov; 18(11):1363-1375. PubMed ID: 23743762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroidal glycosides from the rhizomes of Anemarrhena asphodeloides and their antiplatelet aggregation activity.
    Kang LP; Zhang J; Cong Y; Li B; Xiong CQ; Zhao Y; Tan DW; Yu HS; Yu ZY; Cong YW; Liu C; Ma BP
    Planta Med; 2012 Apr; 78(6):611-6. PubMed ID: 22307934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucosamine suppresses oxidative stress and induces protective autophagy in osteoblasts by blocking the ROS/Akt/mTOR signaling pathway.
    Huang L; Su W; Wu Z; Zheng L; Lv C
    Cell Biol Int; 2022 May; 46(5):829-839. PubMed ID: 35191133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beclin1- and Atg13-dependent autophagy activation and morroniside have synergistic effect on osteoblastogenesis.
    Li X; Zhu Y; Lin X; Chen C; Liu H; Shi Y
    Exp Biol Med (Maywood); 2022 Oct; 247(19):1764-1775. PubMed ID: 35957534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timosaponin AIII: A novel potential anti-tumor compound from Anemarrhena asphodeloides.
    Han FY; Song XY; Chen JJ; Yao GD; Song SJ
    Steroids; 2018 Dec; 140():125-130. PubMed ID: 30296545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroidal saponins from Anemarrhena asphodeloides and their effects on superoxide generation.
    Meng ZY; Zhang JY; Xu SX; Sugahara K
    Planta Med; 1999 Oct; 65(7):661-3. PubMed ID: 10617410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of timosaponin BII on oxidative stress damage in PC12 cells based on metabolomics.
    Xie Q; Zhao H; Li N; Su L; Xu X; Hong Z
    Biomed Chromatogr; 2018 Oct; 32(10):e4321. PubMed ID: 29920723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timosaponin AIII induces apoptosis and autophagy in human melanoma A375-S2 cells.
    Wang Y; Xu L; Lou LL; Song SJ; Yao GD; Ge MY; Hayashi T; Tashiro SI; Onodera S; Ikejima T
    Arch Pharm Res; 2017 Jan; 40(1):69-78. PubMed ID: 27271334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.